601
|
Gomez AC, Warburton KM, Miller RK, Negoianu D, Cohen JB. An Interactive Ambulatory Nephrology Curriculum for Internal Medicine Interns: Design, Implementation, and Participant Feedback. Am J Kidney Dis 2017; 70:415-421. [PMID: 28579421 DOI: 10.1053/j.ajkd.2017.03.022] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2017] [Accepted: 03/25/2017] [Indexed: 01/13/2023]
Abstract
While diminishing nephrology fellow recruitment is a known issue, more work is needed to evaluate possible interventions to reverse this trend. We designed and implemented a curriculum to increase exposure to ambulatory nephrology among internal medicine interns. The curriculum focused on key aspects of outpatient nephrology practice, including supervised clinic visits, formal themed didactic content, and an online interactive forum with assigned evidence-based readings and small-group responses to relevant cases. We obtained postcourse surveys from all participating interns. Of the 43 interns who took part in the first year of the ambulatory nephrology curriculum, 100% reported a positive didactic experience and 91% reported a positive interactive online experience. 77% reported an improvement in their familiarity with clinical nephrology practice (median 2-point increase in familiarity score on a 7-point scale, P<0.001 by signed rank testing). Qualitative feedback included praise for the high-yield topics covered by the lectures and energizing teachers. In conclusion, we successfully implemented an ambulatory nephrology curriculum using a framework that integrated formal didactics, interactive online learning, and key clinical components of outpatient nephrology care. Future investigation will evaluate whether early implementation of this curriculum is associated with increased pursuit of nephrology as a career.
Collapse
Affiliation(s)
- Alexis C Gomez
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
| | | | - Rachel K Miller
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Geriatrics Division, University of Pennsylvania, Philadelphia, PA
| | - Dan Negoianu
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Renal-Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA
| | - Jordana B Cohen
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Renal-Electrolyte and Hypertension Division, University of Pennsylvania, Philadelphia, PA.
| |
Collapse
|
602
|
Totaro M, Casini B, Valentini P, Miccoli M, Giorgi S, Porretta A, Privitera G, Lopalco PL, Baggiani A. Evaluation and control of microbial and chemical contamination in dialysis water plants of Italian nephrology wards. J Hosp Infect 2017; 97:169-174. [PMID: 28546028 DOI: 10.1016/j.jhin.2017.05.011] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2017] [Accepted: 05/16/2017] [Indexed: 11/13/2022]
Abstract
BACKGROUND Patients receiving haemodialysis are exposed to a large volume of dialysis fluid. The Italian Society of Nephrology (ISN) has published guidelines and microbial quality standards on dialysis water (DW) and solutions to ensure patient safety. AIM To identify microbial and chemical hazards, and evaluate the quality of disinfection treatment in DW plants. METHODS In 2015 and 2016, water networks and DW plants (closed loop and online monitors) of nine dialysis wards of Italian hospitals, hosting 162 dialysis beds overall, were sampled on a monthly basis to determine the parameters provided by ISN guidelines. Chlorinated drinking water was desalinated by reverse osmosis and distributed to the closed loop which feeds all online monitors. Disinfection with peracetic acid was performed in all DW plants on a monthly basis. FINDINGS Over the 24-month study period, seven out of nine DW plants (78%) recorded negative results for all investigated parameters. Closed loop contamination with Burkholderia cepacia was detected in a DW plant from January 2015 to March 2015. Pseudomonas aeruginosa was isolated from March 2016 to May 2016 in the closed loop of another DW plant. These microbial contaminations were eradicated by shock disinfection with sodium hypochlorite and peracetic acid, followed by water flushing. CONCLUSION These results highlight the importance of chemical and physical methods of DW disinfection. The maintenance of control measures in water plants hosted in dialysis wards ensures a microbial risk reduction for all dialysis patients.
Collapse
Affiliation(s)
- M Totaro
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - B Casini
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - P Valentini
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - M Miccoli
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - S Giorgi
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - A Porretta
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - G Privitera
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - P L Lopalco
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy
| | - A Baggiani
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
| |
Collapse
|
604
|
Kalantar-Zadeh K, Crowley ST, Beddhu S, Chen JLT, Daugirdas JT, Goldfarb DS, Jin A, Kovesdy CP, Leehey DJ, Moradi H, Navaneethan SD, Norris KC, Obi Y, O’Hare A, Shafi T, Streja E, Unruh ML, Vachharajani T, Weisbord S, Rhee CM. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease. Semin Dial 2017; 30:251-261. [PMID: 28421638 PMCID: PMC5418081 DOI: 10.1111/sdi.12601] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
Each year approximately 13,000 Veterans transition to maintenance dialysis, mostly in the traditional form of thrice-weekly hemodialysis from the start. Among >6000 dialysis units nationwide, there are currently approximately 70 Veterans Affairs (VA) dialysis centers. Given this number of VA dialysis centers and their limited capacity, only 10% of all incident dialysis Veterans initiate treatment in a VA center. Evidence suggests that, among Veterans, the receipt of care within the VA system is associated with favorable outcomes, potentially because of the enhanced access to healthcare resources. Data from the United States Renal Data System Special Study Center "Transition-of-Care-in-CKD" suggest that Veterans who receive dialysis in a VA unit exhibit greater survival compared with the non-VA centers. Substantial financial expenditures arise from the high volume of outsourced care and higher dialysis reimbursement paid by the VA than by Medicare to outsourced providers. Given the exceedingly high mortality and abrupt decline in residual kidney function (RKF) in the first dialysis year, it is possible that incremental transition to dialysis through an initial twice-weekly hemodialysis regimen might preserve RKF, prolong vascular access longevity, improve patients' quality of life, and be a more patient-centered approach, more consistent with "personalized" dialysis. Broad implementation of incremental dialysis might also result in more Veterans receiving care within a VA dialysis unit. Controlled trials are needed to examine the safety and efficacy of incremental hemodialysis in Veterans and other populations; the administrative and health care as well as provider structure within the VA system would facilitate the performance of such trials.
Collapse
Affiliation(s)
- Kamyar Kalantar-Zadeh
- VA Long Beach Healthcare System, Long Beach, California
- Harold Simmons Center for Kidney Disease Research and Epidemiology; Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California
- Los Angeles Biomedical Research Institute, Harbor-UCLA Med. Center, Torrance, California
- Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California
| | - Susan T. Crowley
- VHA National Program Director for Kidney Disease; and Renal Section, VA Connecticut Healthcare System, and Yale University, New Haven, Connecticut
| | - Srinivasan Beddhu
- University of Utah Health Sciences Center, and VA Salt Lake City, Salt Lake City, Utah
| | - Joline LT Chen
- VA Long Beach Healthcare System, Long Beach, California
- Harold Simmons Center for Kidney Disease Research and Epidemiology; Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California
| | | | | | - Anna Jin
- VA Long Beach Healthcare System, Long Beach, California
| | - Csaba P. Kovesdy
- Nephrology Section, Memphis Veterans Affairs Medical Center, and Division of Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee
| | | | - Hamid Moradi
- VA Long Beach Healthcare System, Long Beach, California
- Harold Simmons Center for Kidney Disease Research and Epidemiology; Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California
| | - Sankar D Navaneethan
- Michael E. Debakey VA Medical center and Baylor College of Medicine, Houston, Texas
| | - Keith C Norris
- Department of Medicine, David Geffen UCLA School of Medicine, Los Angeles, California
| | - Yoshitsugu Obi
- VA Long Beach Healthcare System, Long Beach, California
- Harold Simmons Center for Kidney Disease Research and Epidemiology; Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California
| | - Ann O’Hare
- Puget Sounds VA Healthcare System, and University of Washington Seattle, Washington
| | - Tariq Shafi
- Johns Hopkins School of Medicine, Baltimore, Maryland
| | - Elani Streja
- VA Long Beach Healthcare System, Long Beach, California
- Harold Simmons Center for Kidney Disease Research and Epidemiology; Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California
- Los Angeles Biomedical Research Institute, Harbor-UCLA Med. Center, Torrance, California
- Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California
| | - Mark L. Unruh
- New Mexico VA Health Care System, and University of New Mexico; Albuquerque, New Mexico
| | - Tushar Vachharajani
- W. G. (Bill) Hefner VA Medical Center, and Edwards Via College of Osteopathic Medicine, Salisbury, North Carolina
| | - Steven Weisbord
- VA Pittsburgh Healthcare System; and University of Pittsburgh, Pittsburgh, Pennsylvania
| | - Connie M. Rhee
- VA Long Beach Healthcare System, Long Beach, California
- Harold Simmons Center for Kidney Disease Research and Epidemiology; Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California
- Los Angeles Biomedical Research Institute, Harbor-UCLA Med. Center, Torrance, California
| |
Collapse
|